Amphiphilic macromolecule nanoassemblies suppress smooth muscle cell proliferation and platelet adhesion

Biomaterials
Jennifer W ChanKathryn Uhrich

Abstract

While the development of second- and third-generation drug-eluting stents (DES) have significantly improved patient outcomes by reducing smooth muscle cell (SMC) proliferation, DES have also been associated with an increased risk of late-stent thrombosis due to delayed re-endothelialization and hypersensitivity reactions from the drug-polymer coating. Furthermore, DES anti-proliferative agents do not counteract the upstream oxidative stress that triggers the SMC proliferation cascade. In this study, we investigate biocompatible amphiphilic macromolecules (AMs) that address high oxidative lipoprotein microenvironments by competitively binding oxidized lipid receptors and suppressing SMC proliferation with minimal cytotoxicity. To determine the influence of nanoscale assembly on proliferation, micelles and nanoparticles were fabricated from AM unimers containing a phosphonate or carboxylate end-group, a sugar-based hydrophobic domain, and a hydrophilic poly(ethylene glycol) domain. The results indicate that when SMCs are exposed to high levels of oxidized lipid stimuli, nanotherapeutics inhibit lipid uptake, downregulate scavenger receptor expression, and attenuate scavenger receptor gene transcription in SMCs, and thus significa...Continue Reading

References

Aug 22, 1997·The Journal of Biological Chemistry·D Steinberg
Oct 6, 2000·The American Journal of Cardiology·J L OrfordC Rogers
Jan 17, 2003·American Journal of Physiology. Heart and Circulatory Physiology·Marjorie E ZettlerGrant N Pierce
Oct 29, 2003·Proceedings of the National Academy of Sciences of the United States of America·James X RongEdward A Fisher
Dec 29, 2004·Biomaterials·Evangelia ChnariPrabhas V Moghe
Feb 14, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Takahiko NarukoAnton E Becker
Feb 14, 2006·Biomacromolecules·Evangelia ChnariPrabhas V Moghe
Mar 1, 2006·Journal of Clinical Pathology·A K Mitra, D K Agrawal
May 19, 2007·Arteriosclerosis, Thrombosis, and Vascular Biology·Aloke V FinnRenu Virmani
Jun 26, 2007·Atherosclerosis·Rajesh PuranikKerry-Anne Rye
Sep 11, 2007·Nature Medicine·Shaun P Jackson, Anna C Calkin
Sep 11, 2007·Nature Medicine·Michael F Good, Denise L Doolan
Feb 16, 2008·Arteriosclerosis, Thrombosis, and Vascular Biology·Amanda C DoranColeen A McNamara
Dec 17, 2008·Circulation·Donald Lloyd-JonesUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Jan 28, 2009·Circulation·Donald Lloyd-JonesUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Feb 18, 2011·Circulation. Cardiovascular Interventions·Steven O MarxAndrew R Marks
Apr 21, 2011·Circulation. Cardiovascular Interventions·Vasim FarooqPatrick W Serruys
Sep 14, 2011·Circulation·Ajay J Kirtane, Gregg W Stone
Oct 13, 2011·Nature Reviews. Cardiology·J Wouter JukemaPaul H A Quax
Feb 22, 2012·Cardiovascular Research·Sima AllahverdianGordon A Francis
Jan 9, 2013·Nature Reviews. Endocrinology·Makoto Ono, Vincent R Harley
Jul 31, 2013·Biomaterials·Daniel R LewisPrabhas V Moghe
Aug 21, 2014·Accounts of Chemical Research·Li GuKathryn Uhrich
Feb 19, 2015·Proceedings of the National Academy of Sciences of the United States of America·Daniel R LewisPrabhas V Moghe
Jun 5, 2015·Bioconjugate Chemistry·Jennifer W ChanKathryn E Uhrich

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.